Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer
Carol M. Moinpour, Gary W. Donaldson, Astra M. Liepa, Allen S. Melemed, Joyce O’Shaughnessy, Kathy S. AlbainVolume:
21
Language:
english
Pages:
11
DOI:
10.1007/s11136-011-9999-z
Date:
June, 2012
File:
PDF, 392 KB
english, 2012